Page last updated: 2024-11-06

isoflavone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Isoflavones are a type of phytoestrogen found in plants, particularly legumes like soybeans. They are structurally similar to the female hormone estrogen and can interact with estrogen receptors in the body. Isoflavones are synthesized through a series of enzymatic steps involving phenylalanine and tyrosine as precursors. They exhibit a wide range of biological activities, including antioxidant, anti-inflammatory, and anticancer effects. Research has shown potential benefits of isoflavones in reducing the risk of heart disease, osteoporosis, and certain types of cancer. However, further studies are needed to fully understand their long-term effects and optimal dosages. Isoflavones are studied extensively due to their potential health benefits and their unique biological properties. The study of isoflavones aims to elucidate their mechanisms of action, identify their potential therapeutic applications, and assess their safety and efficacy.'

Cross-References

ID SourceID
PubMed CID72304
CHEMBL ID366460
CHEBI ID18220
SCHEMBL ID8028

Synonyms (35)

Synonym
AC-12802
nsc-135405
nsc135405
4h-1-benzopyran-4-one, 3-phenyl-
3-phenyl-4h-1-benzopyran-4-one
3-phenyl-4h-chromen-4-one
isoflavon
CHEBI:18220 ,
3-phenylchromen-4-one
isoflavone ,
C00799
574-12-9
CHEMBL366460
BCP9000133
AKOS015918505
ovo2kuw8h8 ,
nsc 135405
unii-ovo2kuw8h8
FT-0627415
3-phenylchromone
isoflavone [mi]
CCG-214095
SCHEMBL8028
DTXSID90205986
J-521538
CS-W006405
DB12007
DS-6374
BCP22856
mfcd00100851
Q27102918
b-d-glucopyranoside,phenyl2,3-bis-o-(phenylmethyl)-4,6-o-[(r)-phenylmethylene]-1-thio-
AMY33371
HY-W006405
isoflavone - 98%
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
isoflavonesAny isoflavonoid with a 3-aryl-1-benzopyran-4-one (3-aryl-4H-chromen-4-one) skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID1063342Inhibition of aromatase (unknown origin)2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Investigation of fluorinated and bifunctionalized 3-phenylchroman-4-one (isoflavanone) aromatase inhibitors.
AID1819032Antiproliferative activity against human KB cells assessed as reduction in cell viability after 72 hrs by SRB assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Chemical Space Expansion of Flavonoids: Induction of Mitotic Inhibition by Replacing Ring B with a 10π-Electron System, Benzo[
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1204650Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of microbial growth at 10 uM after 5 to 8 days by MABA method2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Synthesis, antimycobacterial evaluation and pharmacophore modeling of analogues of the natural product formononetin.
AID1819033Antiproliferative activity against human KB-VIN cells assessed as reduction in cell viability after 72 hrs by SRB assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Chemical Space Expansion of Flavonoids: Induction of Mitotic Inhibition by Replacing Ring B with a 10π-Electron System, Benzo[
AID404069In vivo antitumor activity against mouse L1210 cells
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1819029Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by SRB assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Chemical Space Expansion of Flavonoids: Induction of Mitotic Inhibition by Replacing Ring B with a 10π-Electron System, Benzo[
AID1819031Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by SRB assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Chemical Space Expansion of Flavonoids: Induction of Mitotic Inhibition by Replacing Ring B with a 10π-Electron System, Benzo[
AID1860355Selectivity index, log ratio of Inhibition of CYP450 in human liver microsomes assessed as inhibition of EpETrE formation in presence of arachidonic acid to Inhibition of CYP450 in human liver microsomes assessed as inhibition of 20-HETE formation in pres
AID1860353Inhibition of CYP450 in human liver microsomes assessed as inhibition of 20-HETE formation at 10 uM in presence of arachidonic acid and NADPH by multi-enzyme assay based LC-MS/MS analysis relative to control
AID1819030Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by SRB assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Chemical Space Expansion of Flavonoids: Induction of Mitotic Inhibition by Replacing Ring B with a 10π-Electron System, Benzo[
AID1860354Inhibition of CYP450 in human liver microsomes assessed as inhibition of EpETrE formation at 10 uM in presence of arachidonic acid and NADPH by multi-enzyme assay based LC-MS/MS analysis relative to control
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 55.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index55.49 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index158.97 (26.88)
Search Engine Supply Index3.78 (0.95)

This Compound (55.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]